Tailored Therapy in Diffuse Gliomas: Using Molecular Classifiers to Optimize Clinical Management

We review the current data regarding the prognostic and predictive value of IDH mutation and 1p/19q codeletion in gliomas. We also discuss possible management algorithms using these biomarkers to tailor surgical and adjuvant therapy for specific diffuse gliomas.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news